Haemonetics Corporation
N/MPrice / tangible book
Market cap
$4.68B
Tangible equity
-$307.70M
Price / tangible book
N/M
Price / book
5.88x
Return on equity
12.2%
Return on assets
4.1%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: HAE stock price at premium vs JPM $102.95 current versus $32.99 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JPM's multiple
Implied fair value · at HAE's multiple
Needs HAE P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple premium
Multiple discount
Profitability lag
Asset efficiency edge
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: HAE FY 2026 (ended Mar 28, 2026) · JPM FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$4.68B
Tangible equity
-$307.70M
Price / tangible book
N/M
Price / book
5.88x
Return on equity
12.2%
Return on assets
4.1%
Efficiency ratio
—
Price / tangible book
Market cap
$953.44B
Tangible equity
$306.21B
Price / tangible book
3.11x
Price / book
2.63x
Return on equity
15.7%
Return on assets
1.3%
Efficiency ratio
109.9%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Haemonetics Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
JPMORGAN CHASE & CO · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.56x
0.18x
Net debt / EBITDA
Leverage against operating earnings
3.80x
—
Cash and equivalents
Liquid reserves on the balance sheet
$245.44M
—
Total debt
Interest-bearing obligations outstanding
$1.24B
$64.78B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BECTON DICKINSON & CO
HAE vs BDX
BAXTER INTERNATIONAL INC
HAE vs BAX
LivaNova PLC
HAE vs LIVN
STERIS plc
HAE vs STE
Bank of America Corporation
HAE vs BAC
Citigroup Inc.
HAE vs C
Wells Fargo & Company
HAE vs WFC
The Goldman Sachs Group, Inc.
HAE vs GS
Morgan Stanley
HAE vs MS
PNC FINANCIAL SERVICES GROUP, INC.
HAE vs PNC
US BANCORP \DE\
HAE vs USB
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.